[Evaluation of 20 years' experience of enuresis in children].
The clinical and urodynamic approach to enuretic children over a period of more than 20 years has allowed the authors to develop a multifactorial pathophysiological concept of this disorder. The main factors involved are psychological, familial, genetic, vesical, due to bladder immaturity, hormonal, due to a defect of nocturnal ADH secretion, hygiene and dietary habits, etc. The sleep factor is predominant in the majority of cases. Although nocturnal enuresis is apparently isolated in many cases, it is often associated with a state of bladder immaturity, sometimes latent during the day, but occurring at night with episodes of detrusor hyperactivity, occurring during various phases of sleep. In practice, the recognition, in children, of these factors, some of which require specific treatments, implies a management combining several of these therapeutic modalities.
Averous
M
M
Service d'Urologie II, Hôpital Lapeyronie, Montpellier, France.
Lopez
C
C
D002648:Child; D002940:Circadian Rhythm; D003131:Combined Modality Therapy; D004775:Enuresis / Q000209:etiology / Q000235:genetics / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy; D005192:Family Health; D005247:Feeding Behavior; D006801:Humans; D006920:Hygiene; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000503:physiopathology; D012076:Renal Agents / Q000378:metabolism / Q000627:therapeutic use; D012890:Sleep; D001743:Urinary Bladder / Q000254:growth & development / Q000503:physiopathology; D001745:Urinary Bladder Diseases / Q000150:complications; D014554:Urination; D014563:Urodynamics; D014667:Vasopressins / Q000378:metabolism / Q000627:therapeutic use
D012076:Renal Agents; D014667:Vasopressins